Antisense Pharma raises EUR 27 million

Antisense Pharma (Regensburg, Germany) raised EUR 27 million ($39.2 million) in a series C round. MIG was the sole investor. Early next year, Antisense plans to begin Phase III testing of AP 12009 to ...